GKOS Stock Summary and Trading Ideas (Glaukos | NYSE:GKOS)

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Glaukos trades on the NYSE stock market under the symbol GKOS.

As of April 24, 2024, GKOS stock price declined to $100.93 with 497,572 million shares trading.

GKOS has a beta of 0.76, meaning it tends to be less sensitive to market movements. GKOS has a correlation of 0.05 to the broad based SPY ETF.

GKOS has a market cap of $5.07 billion. This is considered a Mid Cap stock.

Last quarter Glaukos reported $82 million in Revenue and -$.63 earnings per share. This beat revenue expectation by $4 million and missed earnings estimates by -$.08.

In the last 3 years, GKOS stock traded as high as $103.66 and as low as $33.33.

The top ETF exchange traded funds that GKOS belongs to (by Net Assets): IJR, VTI, IWM, VB, VXF.

GKOS has outperformed the market in the last year with a price return of +103.6% while the SPY ETF gained +24.2%. GKOS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +9.0% and -0.4%, respectively, while the SPY returned +4.6% and -2.7%, respectively.

GKOS support price is $98.52 and resistance is $103.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GKOS stock will trade within this expected range on the day.